{"id":"https://openalex.org/W2889320705","doi":"https://doi.org/10.1007/s10157-018-1635-6","title":"Pharmacodynamics of evocalcet for secondary hyperparathyroidism in Japanese hemodialysis patients","display_name":"Pharmacodynamics of evocalcet for secondary hyperparathyroidism in Japanese hemodialysis patients","publication_year":2018,"publication_date":"2018-08-29","ids":{"openalex":"https://openalex.org/W2889320705","doi":"https://doi.org/10.1007/s10157-018-1635-6","mag":"2889320705","pmid":"https://pubmed.ncbi.nlm.nih.gov/30159688","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6510802"},"language":"en","primary_location":{"id":"doi:10.1007/s10157-018-1635-6","doi":"https://doi.org/10.1007/s10157-018-1635-6","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s10157-018-1635-6","pdf_url":"https://link.springer.com/content/pdf/10.1007/s10157-018-1635-6.pdf","source":{"id":"https://openalex.org/S53361855","display_name":"Clinical and Experimental Nephrology","issn_l":"1342-1751","issn":["1342-1751","1437-7799"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Experimental Nephrology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s10157-018-1635-6.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Evocalcet Study Group","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I190805021","display_name":"Wakayama Medical University","ror":"https://ror.org/005qv5373","country_code":"JP","type":"education","lineage":["https://openalex.org/I190805021"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Evocalcet Study Group","raw_affiliation_strings":["Department of Nephrology, Wakayama Medical University, Wakayama-city, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nephrology, Wakayama Medical University, Wakayama-city, Japan","institution_ids":["https://openalex.org/I190805021"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063644416","display_name":"Takashi Shigematsu","orcid":"https://orcid.org/0000-0002-6330-3784","observed_orcids":["https://orcid.org/0000-0002-6330-3784"]},"institutions":[{"id":"https://openalex.org/I190805021","display_name":"Wakayama Medical University","ror":"https://ror.org/005qv5373","country_code":"JP","type":"education","lineage":["https://openalex.org/I190805021"]},{"id":"https://openalex.org/I205823427","display_name":"Kyowa Kirin (Japan)","ror":"https://ror.org/000wej815","country_code":"JP","type":"company","lineage":["https://openalex.org/I205823427"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Takashi Shigematsu","raw_affiliation_strings":["Department of Nephrology, Wakayama Medical University, 811-1 Kimiidera, Wakayama City, Wakayama, 641-8509, Japan. taki@wakayama-med.ac.jp","R&D Division, Kyowa Hakko Kirin Co. Ltd, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nephrology, Wakayama Medical University, 811-1 Kimiidera, Wakayama City, Wakayama, 641-8509, Japan. taki@wakayama-med.ac.jp","institution_ids":["https://openalex.org/I190805021"]},{"raw_affiliation_string":"R&D Division, Kyowa Hakko Kirin Co. Ltd, Tokyo, Japan","institution_ids":["https://openalex.org/I205823427"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112387851","display_name":"Ryutaro Shimazaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1314466530","display_name":"Tokai University","ror":"https://ror.org/01p7qe739","country_code":"JP","type":"education","lineage":["https://openalex.org/I1314466530"]},{"id":"https://openalex.org/I205823427","display_name":"Kyowa Kirin (Japan)","ror":"https://ror.org/000wej815","country_code":"JP","type":"company","lineage":["https://openalex.org/I205823427"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ryutaro Shimazaki","raw_affiliation_strings":["R&D Division, Kyowa Hakko Kirin Co., Ltd., 1-9-2 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan","Division of Nephrology, Endocrinology and Metabolism Department of Internal Medicine Tokai University School of Medicine Kanagawa Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"R&D Division, Kyowa Hakko Kirin Co., Ltd., 1-9-2 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan","institution_ids":["https://openalex.org/I205823427"]},{"raw_affiliation_string":"Division of Nephrology, Endocrinology and Metabolism Department of Internal Medicine Tokai University School of Medicine Kanagawa Japan","institution_ids":["https://openalex.org/I1314466530"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086510056","display_name":"Masafumi Fukagawa","orcid":"https://orcid.org/0000-0002-7832-2339","observed_orcids":["https://orcid.org/0000-0002-7832-2339"]},"institutions":[{"id":"https://openalex.org/I119182057","display_name":"SHOWA Medical University","ror":"https://ror.org/04mzk4q39","country_code":"JP","type":"education","lineage":["https://openalex.org/I119182057"]},{"id":"https://openalex.org/I1314466530","display_name":"Tokai University","ror":"https://ror.org/01p7qe739","country_code":"JP","type":"education","lineage":["https://openalex.org/I1314466530"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masafumi Fukagawa","raw_affiliation_strings":["Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara-shi, Kanagawa, 259-1193, Japan","Division of Nephrology; Department of Medicine; Showa University School of Medicine; Tokyo Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara-shi, Kanagawa, 259-1193, Japan","institution_ids":["https://openalex.org/I1314466530"]},{"raw_affiliation_string":"Division of Nephrology; Department of Medicine; Showa University School of Medicine; Tokyo Japan","institution_ids":["https://openalex.org/I119182057"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071555943","display_name":"Tadao Akizawa","orcid":"https://orcid.org/0000-0002-6150-9201","observed_orcids":["https://orcid.org/0000-0002-6150-9201"]},"institutions":[{"id":"https://openalex.org/I119182057","display_name":"SHOWA Medical University","ror":"https://ror.org/04mzk4q39","country_code":"JP","type":"education","lineage":["https://openalex.org/I119182057"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tadao Akizawa","raw_affiliation_strings":["Division of Nephrology, Department of Medicine, Showa University School of Medicine, Namics 301, 4-24-51 Takanawa, Minato-ku, Tokyo, 108-0074, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Nephrology, Department of Medicine, Showa University School of Medicine, Namics 301, 4-24-51 Takanawa, Minato-ku, Tokyo, 108-0074, Japan","institution_ids":["https://openalex.org/I119182057"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5063644416"],"corresponding_institution_ids":["https://openalex.org/I190805021","https://openalex.org/I205823427"],"apc_list":{"value":3990,"currency":"USD","value_usd":3990},"apc_paid":{"value":3990,"currency":"USD","value_usd":3990},"fwci":2.485,"has_fulltext":true,"cited_by_count":17,"citation_normalized_percentile":{"value":0.880871,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"23","issue":"2","first_page":"258","last_page":"267"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10516","display_name":"Parathyroid Disorders and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10516","display_name":"Parathyroid Disorders and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10291","display_name":"Dialysis and Renal Disease Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12876","display_name":"Potassium and Related Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/evocalcet","display_name":"evocalcet","score":1.0},{"id":"https://openalex.org/keywords/secondary-hyperparathyroidism","display_name":"secondary hyperparathyroidism","score":0.9909999966621399},{"id":"https://openalex.org/keywords/hemodialysis","display_name":"hemodialysis","score":0.9470000267028809},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9020000100135803},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9100000262260437},{"id":"https://openalex.org/keywords/intact-parathyroid-hormone","display_name":"intact parathyroid hormone","score":0.9190000295639038},{"id":"https://openalex.org/keywords/serum-calcium","display_name":"serum calcium","score":0.8690000176429749},{"id":"https://openalex.org/keywords/serum-phosphorus","display_name":"serum phosphorus","score":0.8149999976158142},{"id":"https://openalex.org/keywords/fgf23","display_name":"fibroblast growth factor 23","score":0.9980000257492065},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.7609999775886536},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.7480000257492065},{"id":"https://openalex.org/keywords/calcium-reduction","display_name":"calcium reduction","score":0.3310000002384186},{"id":"https://openalex.org/keywords/japanese-patients","display_name":"Japanese patients","score":0.6309999823570251}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8984922170639038},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.8331962823867798},{"id":"https://openalex.org/C2778838027","wikidata":"https://www.wikidata.org/wiki/Q3622611","display_name":"Secondary hyperparathyroidism","level":4,"score":0.7515498399734497},{"id":"https://openalex.org/C2781208988","wikidata":"https://www.wikidata.org/wiki/Q202476","display_name":"Parathyroid hormone","level":3,"score":0.689429759979248},{"id":"https://openalex.org/C2778063415","wikidata":"https://www.wikidata.org/wiki/Q391744","display_name":"Hemodialysis","level":2,"score":0.6782994866371155},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6565828323364258},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6516965627670288},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5738545060157776},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.479265421628952},{"id":"https://openalex.org/C54847362","wikidata":"https://www.wikidata.org/wiki/Q177635","display_name":"Nephrology","level":2,"score":0.45700231194496155},{"id":"https://openalex.org/C2775945674","wikidata":"https://www.wikidata.org/wiki/Q1344835","display_name":"Hyperparathyroidism","level":2,"score":0.45131707191467285},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.42791423201560974},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4164654314517975},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.38257884979248047}],"mesh":[{"descriptor_ui":"D000089703","descriptor_name":"Fibroblast Growth Factor-23","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002118","descriptor_name":"Calcium","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005346","descriptor_name":"Fibroblast Growth Factors","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006435","descriptor_name":"Renal Dialysis","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006962","descriptor_name":"Hyperparathyroidism, Secondary","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006962","descriptor_name":"Hyperparathyroidism, Secondary","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D006962","descriptor_name":"Hyperparathyroidism, Secondary","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006962","descriptor_name":"Hyperparathyroidism, Secondary","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009281","descriptor_name":"Naphthalenes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D009281","descriptor_name":"Naphthalenes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D009281","descriptor_name":"Naphthalenes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010281","descriptor_name":"Parathyroid Hormone","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D010758","descriptor_name":"Phosphorus","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057966","descriptor_name":"Calcimimetic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D057966","descriptor_name":"Calcimimetic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D057966","descriptor_name":"Calcimimetic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D057966","descriptor_name":"Calcimimetic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1007/s10157-018-1635-6","doi":"https://doi.org/10.1007/s10157-018-1635-6","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s10157-018-1635-6","pdf_url":"https://link.springer.com/content/pdf/10.1007/s10157-018-1635-6.pdf","source":{"id":"https://openalex.org/S53361855","display_name":"Clinical and Experimental Nephrology","issn_l":"1342-1751","issn":["1342-1751","1437-7799"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Experimental Nephrology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5504733","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6510802","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6510802","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6510802","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Exp Nephrol","raw_type":"Text"},{"id":"pmid:30159688","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30159688","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and experimental nephrology","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":{"id":"doi:10.1007/s10157-018-1635-6","doi":"https://doi.org/10.1007/s10157-018-1635-6","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s10157-018-1635-6","pdf_url":"https://link.springer.com/content/pdf/10.1007/s10157-018-1635-6.pdf","source":{"id":"https://openalex.org/S53361855","display_name":"Clinical and Experimental Nephrology","issn_l":"1342-1751","issn":["1342-1751","1437-7799"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Experimental Nephrology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320322359","display_name":"Kyowa Hakko Kirin","ror":"https://ror.org/0586k5242"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2889320705.pdf","grobid_xml":"https://content.openalex.org/works/W2889320705.grobid-xml"},"referenced_works_count":20,"referenced_works":["https://openalex.org/W1951231368","https://openalex.org/W1969259155","https://openalex.org/W1987176542","https://openalex.org/W2003983964","https://openalex.org/W2004079745","https://openalex.org/W2031721753","https://openalex.org/W2041760235","https://openalex.org/W2086421534","https://openalex.org/W2096182653","https://openalex.org/W2098126388","https://openalex.org/W2102964231","https://openalex.org/W2107207648","https://openalex.org/W2127561755","https://openalex.org/W2136991956","https://openalex.org/W2270218478","https://openalex.org/W2333026327","https://openalex.org/W2468173587","https://openalex.org/W2730786221","https://openalex.org/W2796450262","https://openalex.org/W2889629564"],"related_works":["https://openalex.org/W2889629564","https://openalex.org/W3022601918","https://openalex.org/W2898905274","https://openalex.org/W2941142102","https://openalex.org/W4311263350","https://openalex.org/W4392626906","https://openalex.org/W4386258854","https://openalex.org/W2926580298","https://openalex.org/W6925423471","https://openalex.org/W3100087401"],"abstract_inverted_index":{"BACKGROUND:":[0],"This":[1],"study":[2],"investigated":[3],"the":[4,111],"pharmacokinetics,":[5],"pharmacodynamics,":[6],"and":[7,32,42,59,86,125,135,179],"safety":[8],"of":[9,12,40,54,57,75,77,98,114,137,142,161,194],"multiple":[10,38,55,140,159],"doses":[11,39,56,141,160,193],"evocalcet":[13,45,62,103,120,195],"in":[14,133,154,204,212],"Japanese":[15],"secondary":[16],"hyperparathyroidism":[17],"(SHPT)":[18],"patients":[19,36,138,156,214],"receiving":[20,139,215],"hemodialysis.":[21,216],"METHODS:":[22],"In":[23],"this":[24],"multicenter,":[25],"open-label":[26],"study,":[27],"conducted":[28],"between":[29],"August":[30],"2013":[31],"March":[33],"2014,":[34],"27":[35],"received":[37],"1":[41,143],"4":[43,145,162],"mg":[44,61],"for":[46,63,169],"14":[47],"days,":[48],"followed":[49],"by":[50,96],"an":[51,67],"extension":[52],"period":[53],"8":[58],"12":[60],"7":[64],"days":[65,109],"using":[66],"intra-patient":[68],"dose":[69],"escalation":[70],"protocol.":[71],"Pharmacodynamic":[72,116],"parameters":[73],"consisted":[74],"measurement":[76],"intact":[78,87,123,197],"parathyroid":[79],"hormone":[80],"(PTH),":[81],"serum-corrected":[82,126],"calcium,":[83],"serum":[84,205],"phosphorus":[85],"fibroblast":[88],"growth":[89],"factor":[90],"23":[91],"concentrations.":[92],"Safety":[93],"was":[94,209],"assessed":[95],"analysis":[97],"adverse":[99,185],"events.":[100],"RESULTS:":[101],"Plasma":[102],"levels":[104,199],"reached":[105],"steady":[106],"state":[107],"3":[108],"after":[110,158],"first":[112],"day":[113],"administration.":[115],"analyses":[117],"showed":[118],"that":[119],"effectively":[121],"reduced":[122,196],"PTH":[124,198],"calcium":[127,151,189,206],"levels.":[128,207],"Adverse":[129],"events":[130,165],"(AEs)":[131],"occurred":[132,153],"29.6":[134],"62.5%":[136],"or":[144],"mg,":[146],"respectively.":[147],"The":[148],"AE":[149,175],"'blood":[150],"decreased'":[152],"eight":[155],"(33.0%)":[157],"mg.":[163],"All":[164],"were":[166],"mild,":[167],"except":[168],"one":[170,180],"patient":[171,181],"with":[172,182,200],"a":[173,183,201],"moderate":[174],"(abnormal":[176],"liver":[177],"function)":[178],"severe":[184],"drug":[186],"reaction":[187],"(blood":[188],"decreased).":[190],"CONCLUSION:":[191],"Multiple":[192],"concomitant":[202],"decrease":[203],"Evocalcet":[208],"well":[210],"tolerated":[211],"SHPT":[213]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2018-09-07T00:00:00"}